These results are supported by in vivo experiments in the DEN-induced rat model, whereby CK inhibited the growth of primary liver cancer, down-regulated the expression of Bclaf1 and HIF-1α, promoted the ubiquitination degradation of HIF-1α, and inhibited glycolysis. Here, BCLAF1 is linked to liver cancer.